Spartin, Spastic paraplegia 20 protein, Trans-activated by hepatitis C virus core protein 1, SPG20, KIAA0610, TAHCCP1
Product description
SPG20 is a protein containing a MIT (Microtubule
Interacting and Trafficking molecule) domain, and is implicated in
regulating endosomal trafficking and mitochondria function. The
protein localizes to mitochondria and partially co-localizes with
microtubules. Stimulation with epidermal growth factor (EGF)
results in protein translocation to the plasma membrane, and the
protein functions in the degradation and intracellular trafficking
of EGF receptor. Multiple alternatively spliced variants, encoding
the same protein, have been identified. Mutations associated with
this gene cause autosomal recessive spastic paraplegia 20 (Troyer
syndrome).1) Hooper, C., et al. BMC Biol. 8, 72 (2010) :
Immunogen
This SPG20 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 491-519 amino acids from the C-terminal region of human SPG20.
Western blot analysis in 293 cell line lysates (35ug/lane).
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.